Literature DB >> 21559006

Chromatin immunoprecipitation assay for tissue-specific genes using early-stage mouse embryos.

Ok Hyun Cho1, Jaime A Rivera-Pérez, Anthony N Imbalzano.   

Abstract

Chromatin immunoprecipitation (ChIP) is a powerful tool to identify protein:chromatin interactions that occur in the context of living cells. This technique has been widely exploited in tissue culture cells, and to a lesser extent, in primary tissue. The application of ChIP to rodent embryonic tissue, especially at early times of development, is complicated by the limited amount of tissue and the heterogeneity of cell and tissue types in the embryo. Here we present a method to perform ChIP using a dissociated embryonic day 8.5 (E8.5) embryo. Sheared chromatin from a single E8.5 embryo can be divided into up to five aliquots, which allows the investigator sufficient material for controls and for investigation of specific protein:chromatin interactions. We have utilized this technique to begin to document protein:chromatin interactions during the specification of tissue-specific gene expression programs. The heterogeneity of cell types in an embryo necessarily restricts the application of this technique because the result is the detection of protein:chromatin interactions without distinguishing whether the interactions occur in all, a subset of, or a single cell type(s). However, examination of tissue-specific genes during or following the onset of tissue-specific gene expression is feasible for two reasons. First, immunoprecipitation of tissue specific factors necessarily isolates chromatin from the cell type where the factor is expressed. Second, immunoprecipitation of coactivators and histones containing post-translational modifications that are associated with gene activation should only be found at genes and gene regulatory sequences in the cell type where the gene is being or has been activated. The technique should be applicable to the study of most tissue-specific gene activation events. In the example described below, we utilized E8.5 and E9.5 mouse embryos to examine factor binding at a skeletal muscle specific gene promoter. Somites, which are the precursor tissues from which the skeletal muscles of the trunk and limbs will form, are present at E8.5-9.5. Myogenin is a regulatory factor required for skeletal muscle differentiation. The data demonstrate that myogenin is associated with its own promoter in E8.5 and E9.5 embryos. Because myogenin is only expressed in somites at this stage of development, the data indicate that myogenin interactions with its own promoter have already occurred in skeletal muscle precursor cells in E8.5 embryos.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559006      PMCID: PMC3197424          DOI: 10.3791/2677

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

Review 1.  In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment.

Authors:  M H Kuo; C D Allis
Journal:  Methods       Date:  1999-11       Impact factor: 3.608

Review 2.  The formation of skeletal muscle: from somite to limb.

Authors:  Margaret Buckingham; Lola Bajard; Ted Chang; Philippe Daubas; Juliette Hadchouel; Sigolène Meilhac; Didier Montarras; Didier Rocancourt; Frédéric Relaix
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 3.  Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation.

Authors:  Kirby D Johnson; Emery H Bresnick
Journal:  Methods       Date:  2002-01       Impact factor: 3.608

4.  An initial blueprint for myogenic differentiation.

Authors:  Alexandre Blais; Mary Tsikitis; Diego Acosta-Alvear; Roded Sharan; Yuval Kluger; Brian David Dynlacht
Journal:  Genes Dev       Date:  2005-02-10       Impact factor: 11.361

5.  Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters.

Authors:  Yi Cao; Roshan M Kumar; Bennett H Penn; Charlotte A Berkes; Charles Kooperberg; Laurie A Boyer; Richard A Young; Stephen J Tapscott
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

Review 6.  The eventful somite: patterning, fate determination and cell division in the somite.

Authors:  Faisal Yusuf; Beate Brand-Saberi
Journal:  Anat Embryol (Berl)       Date:  2006-09-26

7.  Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis.

Authors:  Yasuyuki Ohkawa; Saori Yoshimura; Chiduru Higashi; Concetta G A Marfella; Caroline S Dacwag; Taro Tachibana; Anthony N Imbalzano
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

Review 8.  Analysis of epigenetic alterations to chromatin during development.

Authors:  Meghan E Minard; Abhinav K Jain; Michelle Craig Barton
Journal:  Genesis       Date:  2009-08       Impact factor: 2.487

9.  Myogenin gene disruption results in perinatal lethality because of severe muscle defect.

Authors:  Y Nabeshima; K Hanaoka; M Hayasaka; E Esumi; S Li; I Nonaka; Y Nabeshima
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

10.  Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.

Authors:  Judith K Davie; Jang-Hyeon Cho; Eric Meadows; Jesse M Flynn; Jennifer R Knapp; William H Klein
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

View more
  4 in total

1.  Hoxc8 initiates an ectopic mammary program by regulating Fgf10 and Tbx3 expression and Wnt/β-catenin signaling.

Authors:  Lara S Carroll; Mario R Capecchi
Journal:  Development       Date:  2015-10-12       Impact factor: 6.868

2.  Contrasting roles for MyoD in organizing myogenic promoter structures during embryonic skeletal muscle development.

Authors:  Ok Hyun Cho; Chandrashekara Mallappa; J Manuel Hernández-Hernández; Jaime A Rivera-Pérez; Anthony N Imbalzano
Journal:  Dev Dyn       Date:  2014-11-03       Impact factor: 3.780

3.  The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.

Authors:  J Manuel Hernández-Hernández; Chandrashekara Mallappa; Brian T Nasipak; Steffi Oesterreich; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

4.  LncRNA-HIT Functions as an Epigenetic Regulator of Chondrogenesis through Its Recruitment of p100/CBP Complexes.

Authors:  Hanqian L Carlson; Jeffrey J Quinn; Yul W Yang; Chelsea K Thornburg; Howard Y Chang; H Scott Stadler
Journal:  PLoS Genet       Date:  2015-12-03       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.